2. Jennings B, Prinsley P, Philpott C, Willis G, Bhutta M. The genetics of cholesteatoma. A systematic review using narrative synthesis. Clinical Otolaryngology. 2017;43(1):55-67.
4. Jackler R, Santa Maria P, Varsak Y, Nguyen A, Blevins N. A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction. The Laryngoscope. 2015;125:S1-S14.
7. Kuo C. Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research. The Laryngoscope. 2014;125(1):234-240.
9. Kansu L, Ozluoglu L. Congenital cholesteatoma together with ossicular chain anomaly. European Archives of Oto-Rhino-Laryngology. 2016;274(2):1179-1182.
10. Kuo C, Shiao A, Wen H, Chang W. Increased risk of cholesteatoma among patients with allergic rhinitis: A nationwide investigation. The Laryngoscope. 2017;128(3):547-553.
11. Walker D, Shinners M. Congenital Cholesteatoma. Pediatric Annals. 2016;45(5):e167-e170.
12. Wang T, Lin C, Lin C, Chung H, Wang C, Tsai M et al. Increased Acquired Cholesteatoma Risk in Patients with Osteoporosis: A Retrospective Cohort Study. PLOS ONE. 2015;10(7):e0132447.
13. Kuo C, Yen Y, Chang W, Shiao A. Association Between Middle Ear Cholesteatoma and Chronic Rhinosinusitis. JAMA Otolaryngology–Head & Neck Surgery. 2017;143(8):757.
14. Chen A, Wang B, Zhong F, Song G, Song H, Yu K et al. Expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin are associated with middle ear cholesteatoma risk. Acta Oto-Laryngologica. 2015;135(7):655-666.